Since the first clinical observation of HIV/AIDS in 1981, some 35.4 million people have died from AIDS-related illnesses.
Investigators evaluated the safety and effectiveness of conventional therapy with biologic immunosuppressive drugs to treat patients with HIV infection and psoriasis.
Increased proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in people with HIV may be related to abnormal coronary endothelial function.
The FDA has approved Temixys tablets for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients weighing ≥35kg.
Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.
Screening recommended for those ages 15 to 65 years, including pregnant women.
Increased cancer prevention, screening, and treatment are needed for people living with HIV both before and after an initial cancer diagnosis.
The new "F4" formulation is 4 times more concentrated than the version currently available on the market.
ART prior to becoming pregnant was linked with reduced risk for hospitalization because of infections in seronegative infants who are exposed to HIV.
Ensuring access to HIV services and harm-reduction interventions earlier could substantially reduce HIV incidence over the course of an actual outbreak.
Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination.
Infectious Disease Advisor speaks with Elizabeth D. Lowenthal, MD, about the challenges associated with revealing HIV seropositive status to children.
Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.
Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.
Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.
Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.
The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future interventions.
Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.
The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).
Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.
SIGN UP FOR FREE E-NEWSLETTERS
Infectious Disease Advisor Articles
- Isavuconazole Not Noninferior to Caspofungin for Invasive Candida Infections
- Dundee Severity Classification Improves Management of Patients With Cellulitis
- Three New Ebola Vaccines Demonstrate Persistent Immune Response
- Pregnant Women Commonly Refuse Vaccines
- Tap Water in Neti Pot Linked to Death From Brain-Eating Amoeba
- Prenatal Malaria Exposure Modulates Innate Immune Responses at Birth
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- A Single Triple-Drug Treatment for Lymphatic Filariasis
- Cyclosporiasis Cases Markedly Higher in 2018 Than Previous 2 Years
- Mail-Based HPV Testing May Increase Access